Necrotizing Fasciitis Associated with Staphylococcus lugdunensis by Hung, Tony et al.
Hindawi Publishing Corporation
Case Reports in Infectious Diseases
Volume 2012, Article ID 453685, 3 pages
doi:10.1155/2012/453685
Case Report
NecrotizingFasciitisAssociatedwith
Staphylococcuslugdunensis
Tony Hung,1,2 SoroushZaghi,1 Jonathan Yousefzadeh,1 andMatthew Leibowitz2
1Department of General Surgery, David Geﬀen School of Medicine at UCLA, Los Angeles, CA 90095, USA
2Division of Infectious Diseases, Department of Medicine, David Geﬀen School of Medicine at UCLA, Los Angeles, CA 90095, USA
Correspondence should be addressed to Soroush Zaghi, soroush.zaghi@gmail.com
Received 5 February 2012; Accepted 21 March 2012
Academic Editors: A. Marangoni and X. Vall` es
Copyright © 2012 Tony Hung et al. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Necrotizingfasciitisisalife-threateningsofttissueinfectionthatresultsinrapidlocaltissuedestruction.Type1necrotizingfasciitis
is characterized by polymicrobial, synergistic infections that are caused by non-Group A streptococci, aerobic and anaerobic
organisms. Type 2 necrotizing fasciitis involves Group A Streptococcus (GAS) with or without a coexisting staphylococcal
infection. Here we provide the ﬁrst report of necrotizing fasciitis jointly associated with the microbes Group B Streptococcus and
Staphylococcus lugdunensis. S. lugdunensis is a commensal human skin bacterium known to cause often painful and prolonged skin
and soft tissue infections. To our knowledge, however, this is the ﬁrst case of Staph. lugdunensis-associated necrotizing fasciitis to
be reported in the literature.
1.Introduction
The spectrum of disease-causing microbes continues to
change rapidly. Not only are we documenting an alarming
increase in antimicrobial resistance but also we are now
detecting an emerging tendency for infectious disease patho
gens to develop greater degrees of virulence. Necrotizing
fasciitis (NF) is a rapidly progressing, life- and limb-
threatening soft tissue infection that targets the superﬁcial
fascial tissue layer. The disease is characterized by quickly
spreading erythema, pronounced tenderness, severe pain,
subcutaneous gas, fever, and tachycardia [1]. Whereas a
number of pathogens including Group A Streptococcus,
Enterobacteriaceae, Clostridium perfringens,a n dStaphylo-
coccus aureus have commonly been associated with necro-
tizing fasciitis, a growing number of unprecedented bacteria
are also becoming associated with this severe soft tissue
infection. As necrotizing fasciitis is a potentially lethal and
devastating infectious disease process, it is important that
novel virulence patterns be documented and addressed as
soon as they are detected. Here we report the ﬁrst case of
necrotizingfasciitistobeassociatedwiththemicrobeStaphy-
lococcus lugdunensis.
2.Case
A 66-year-old African American woman with osteoporosis,
osteoarthritis, and impaired glucose tolerance presented
to the emergency department with a 5-day history of left
groin pain, nausea, vomiting, and fatigue. Five days prior to
admission, she had noted an abscess on her inner left thigh
that progressively ruptured and drained purulent, bloody
material. On evaluation, she was tachycardic (HR: 111–136)
and febrile to 103.2◦F. The left thigh wound drained a thin
serous and dishwater-type ﬂuid. Labs revealed leukocytosis
and hyperglycemia (WBCs = 23.8 × 103: 86.4% neutrophils,
5.4% lymph, 8.1% monocyte; glucose: 239g/dL; BUN
13mg/dL, creatinine 0.6mg/dL, chloride 92mmol/L, total
CO2 24mmol/dL, total creatinine kinase = 67mg/dL). CT
scan showed a 4.6 × 1.4 × 5cm ﬂuid collection proximal to
the left gracilis muscles with presence of gas bubbles, edema,
and fat stranding in the subcutaneous tissues. The patient
was taken emergently to the operating room to undergo
radical debridement, washout, packing, and subsequently
admitted for IV antibiotic therapy.
Microscopic analysis of the debrided specimen revealed
areas of necrosis and acute and chronic inﬂammation,2 Case Reports in Infectious Diseases
Figure 1: Microbiology culture and sensitivity report from initial debridement.
consistent with a diagnosis of necrotizing fasciitis. Gram
stainoftheinitial intraoperativespecimenshowed“fewgram
p o s i t i v ec o c c ii np a i r sa n dc h a i n s , ” and ﬁnal bacterial culture
showed many GBS, moderate S. lugdunensis,a n dm o d e r -
ate Corynebacterium (see Figure 1). Subsequent additional
debridementgrewmanyGBSandmanyS.lugdunensis.Blood
cultures were negative. Blood tests for HIV 1, HIV 2,
hepatitis B, and hepatitis C were negative. QuantiFERON
goldtuberculosistestwasnegative.Duringthecourseofhos-
pitalization, the patient was empirically treated with IV
antibiotics including vancomycin, clindamycin, and aztre-
onam. After multiple debridements, the patient underwent
plastic surgery reconstruction of her left groin. She was
discharged home in stable condition after a 67-day hospital
course and is doing well at followup 18 months later.
3. Discussion
Necrotizing fasciitis (NF) is a life-threatening soft tissue
infection that results in rapid local tissue destruction of
primarily the superﬁcial fascia; the infective process is
characterized by angiothrombotic microbial invasion and
liquefactive necrosis of the deep dermis and fascia [1].
Estimated 500 to 1,500 cases of NF are diagnosed each year
in the United States with a case-fatality rate of 24% [2].
While surgical debridement is the essential treatment of
NF, addition of broad-spectrum antibiotics at the time of
presentation and further appropriate antimicrobial therapy
targeted for speciﬁc causative microbes may modify the
clinical picture and are also critical in the management of
this infectious process [1, 2].
NF is traditionally classiﬁed into two distinct categories
based on the causative microorganisms [2]. Type 1 NF is
characterized by polymicrobial, synergistic infections that
are caused by non-Group-A streptococci, aerobic and anaer-
obic organisms [1]. Type 2 NF involves Group A Streptococ-
cus (GAS) with or without a coexisting staphylococcal infec-
tion [2]. While the clinical manifestations are similar, type 1
and type 2 NF tend to aﬀect diﬀerent subgroups of patients.
Type 1 NF has a propensity to aﬀect diabetic and immuno-
compromised individuals, whereas type 2 NF tends to occur
in individuals with no underlying comorbidities [1]. Both
type 1 and type 2 NF are considered surgical emergencies;
appropriate management requires comprehensive surgical
debridement combined with targeted antimicrobial therapy
and physiologic support [3].
Because of the importance of targeted antibiotic therapy
in the treatment of NF, awareness of the spectrum of
microbes that might be associated with NF is imperative.
Microbes commonly associated with NF include: Group A
Streptococcus, Clostridium perfringens, methicillin-sensitive
Staphylococcus aureus, Enterobacteriaceae, E. coli, Pseud-
omonas spp., Klebsiella spp., V. vulniﬁcus, A. hydrophila, and
anaerobic Streptococcus spp. [1]. While these microbes
comprise most of all cases, other pathogens such as MRSA
and Group B Streptococcus (GBS) have also been associated
withNFonrareoccasions[4].Herewedocumentfortheﬁrst
time a case of NF caused by a polymicrobial combination of
Group B Streptococcus and Staphylococcus lugdunensis.Case Reports in Infectious Diseases 3
Staphylococcus lugdunensis is a commensal human skin
bacterium ﬁrst described in 1988 and since reported as a
cause of prolonged and recurrent skin and soft tissue infec-
tions, as well as serious infections including meningitis,
ventriculoperitoneal shunt infection, spondylodiscitis, pros-
thetic joint infection, catheter-related bacteremia, endo-
carditis, and pacemaker-related infections [5, 6]. S. lug-
dunensis is a coagulase-negative Staphylococcus with a path-
ogenicityandvirulencemoresimilartoStaphylococcusaureus
than to other coagulase-negative Staphylococcus spp.. In fact,
these organisms are frequently misidentiﬁed as S. aureus
because of their morphologic appearance with yellow pig-
mentation and complete hemolysis when cultured on blood
agar. Even so, appropriate identiﬁcation of S. lugdunensis is
imperative as misidentiﬁcation may result in inadequately
treated, prolonged, and persistent infection [6].
Indeed, S. lugdunensis comprises a niche that is distinctly
diﬀerent from those of S. aureus [7, 8]; S. lugdunensis is
an integral part of the normal skin ﬂora, predominant at
the abdomen, groin, and lower extremities (especially the
nail bed of the ﬁrst toe) and is only rarely obtained from
cultures of nasal swabs—a pattern of distribution distinct
from S. aureus [7, 9]. Moreover, its characteristic antibiotic
susceptibility proﬁle is unusual for both coagulase-negative
and coagulase-positive staphylococci. S. lugdunensis typically
lacks the mecA gene, which codes for penicillin binding pro-
tein (PBP) 2a and induces methicillin resistance [10]. More-
over, because only about 20% of isolates are beta-lactamase-
positive, it is often possible to use penicillin for treatment
of infections caused by these organisms. In addition, S. lug-
dunensisisalsousuallysusceptibletogentamicin,rifampicin,
vancomycin, oxacillin, and cefoxitin, and <10% of isolates
are found to be resistant to clindamycin or fusidic acid [5].
According to a 5-year consecutive record review by Her-
chline and Ayers, approximately 10.1% of isolated staphylo-
coccal species that were not S. aureus or S. epidermidis were
indeed identiﬁed as S. lugdunensis [11]. The most common
clinical diagnoses were skin and skin structure infections
(55.4%) and blood and vascular catheter infections (17.4%).
For 40% of the reviewed specimens, S. lugdunensis was the
sole agent isolated, and for 60% of specimens, S. lugdunensis
was isolated as part of mixed ﬂora. In only 15.4% of
clinically reviewed specimens was S. lugdunensis clearly a
culture contaminant or colonizing organism. The pattern
of human infection identiﬁed in that study emphasizes the
predominance of S. lugdunensis to aﬀect skin and soft tissue
structures[11].Evenso,thishereistheﬁrstreportofanasso-
ciation of S. lugdunensis with the fulminant manifestation of
necrotizing fasciitis.
4. Conclusion
S.lugdunensisisa commoncauseofskin andsofttissueinfec-
tions (SSTIs) that is likely underrated by many laboratories.
S. lugdunensis is distinct in both niche, clinical spectrum
of disease, and antibiotic sensitivity in comparison to other
staphylococcal species. This case report demonstrates the
potentialofS.lugdunensistocauseSSTIasextensiveasnecro-
tizing fasciitis. As such, S. lugdunensis should be accepted
as a clinically signiﬁcant human pathogen and should be
distinctly identiﬁed and included in all routine bacteriologi-
cal examinations. Clinicians should be acquainted with the
name and the pathology of the bacterium. Moreover, this
casereportalsoidentiﬁesGroupBStreptococcusasasynergis-
tic microbe in this case of NF associated with S. lugdunensis.
References
[1] C. H. Wong, H. C. Chang, S. Pasupathy, L. W. Khin, J. L. Tan,
and C. O. Low, “Necrotizing fasciitis: clinical presentation,
microbiology, and determinants of mortality,” Journal of Bone
and Joint Surgery—Series A, vol. 85, no. 8, pp. 1454–1460,
2003.
[2] T. Shimizu and Y. Tokuda, “Necrotizing fasciitis,” Internal
Medicine, vol. 49, no. 12, pp. 1051–1057, 2010.
[3] D. A. Anaya and E. P. Dellinger, “Necrotizing soft-tissue infec-
tion: diagnosis and management,” Clinical Infectious Diseases,
vol. 44, no. 5, pp. 705–710, 2007.
[ 4 ] C .H .W o n g ,A .K u r u p ,a n dK .C .T a n ,“ G r o u pBStreptococcus
necrotizingfasciitis:anemergingdisease?”EuropeanJournalof
Clinical Microbiology and Infectious Diseases,v o l .2 3 ,n o .7 ,p p .
573–575, 2004.
[5] C.Hellbacher,E.Tornqvist,andB.Soderquist,“Staphylococcus
lugdunensis: clinical spectrum, antibiotic susceptibility, and
phenotypic and genotypic patterns of 39 isolates,” Clinical
Microbiology and Infection, vol. 12, no. 1, pp. 43–49, 2006.
[ 6 ]H .S e i f e r t ,D .O l t m a n n s ,K .B e c k e r ,H .W i s p l i n g h o ﬀ,a n d
C. Von Eiﬀ,“ Staphylococcus lugdunensis pacemaker-related
infection,” Emerging Infectious Diseases,v o l .1 1 ,n o .8 ,p p .
1283–1286, 2005.
[7] L. Bieber and G. Kahlmeter, “Staphylococcus lugdunensis in
several niches of the normal skin ﬂora,” Clinical Microbiology
and Infection, vol. 16, no. 4, pp. 385–388, 2010.
[ 8 ] T .Y .T a n ,S .Y .N g ,a n dJ .H e ,“ M i c r o b i o l o g i c a lc h a r a c t e r i s t i c s ,
presumptive identiﬁcation, and antibiotic susceptibilities of
Staphylococcus lugdunensis,” Journal of Clinical Microbiology,
vol. 46, no. 7, pp. 2393–2395, 2008.
[9] S. Bocher, B. Tonning, R. L. Skov, and J. Prag, “Staphylococcus
lugdunensis, a common cause of skin and soft tissue infections
in the community,” Journal of Clinical Microbiology, vol. 47,
no. 4, pp. 946–950, 2009.
[10] J. R. Ebright, N. Penugonda, and W. Brown, “Clinical experi-
ence with Staphylococcus lugdunensis bacteremia: a retrospec-
tive analysis,” Diagnostic Microbiology and Infectious Disease,
vol. 48, no. 1, pp. 17–21, 2004.
[11] T. E.Herchline andL. W. Ayers,“Occurrence ofStaphylococcus
lugdunensis in consecutive clinical cultures and relationship of
isolation to infection,” Journal of Clinical Microbiology, vol. 29,
no. 3, pp. 419–421, 1991.